Rhythm Pharmaceuticals (RYTM) Interest Coverage Ratio (2022 - 2025)
Historic Interest Coverage Ratio for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to 11.1.
- Rhythm Pharmaceuticals' Interest Coverage Ratio fell 3263.02% to 11.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 8.7, marking a year-over-year increase of 3728.67%. This contributed to the annual value of 12.89 for FY2024, which is 289.44% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 11.1 for Q3 2025, which was down 3263.02% from 7.79 recorded in Q2 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Interest Coverage Ratio peaked at 7.57 during Q4 2024, and registered a low of 980.35 during Q2 2022.
- Moreover, its 4-year median value for Interest Coverage Ratio was 12.53 (2023), whereas its average is 82.05.
- In the last 5 years, Rhythm Pharmaceuticals' Interest Coverage Ratio surged by 9856.08% in 2023 and then plummeted by 7142.51% in 2024.
- Over the past 4 years, Rhythm Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 13.98 in 2022, then surged by 35.14% to 9.07 in 2023, then grew by 16.49% to 7.57 in 2024, then tumbled by 46.6% to 11.1 in 2025.
- Its last three reported values are 11.1 in Q3 2025, 7.79 for Q2 2025, and 8.69 during Q1 2025.